DavidSchneiderMD

Cardiology • Burlington, VT

Adult Congenital Heart Disease, Echocardiography

Physician

Join to view full profile

Dr. Schneider is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schneider's full profile

Already have an account?

Office
111 Colchester Ave
Cardiology Division
Burlington, VT 05401
Phone+1 802-547-2879

Fax+1 802-847-2533

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1990 - 1994
University of ColoradoResidency, Internal Medicine, 1986 - 1990
University of Cincinnati College of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 1999 - 2026
VT State Medical License 1994 - 2026
CO State Medical License 1987 - 1991
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Cangrelor Ticagrelor Transition Study Start of enrollment: 2013 Jan 01
Completed
Phase 2
Cangrelor Prasugrel Transition Study Start of enrollment: 2013 Jun 01
Completed
Phase 2
Cangrelor to Clopidogrel or Prasugrel Transition Study Start of enrollment: 2013 Dec 02
Completed
Phase 2
Novel Biomarkers of Thrombotic Risk Start of enrollment: 2015 Jul 01
Completed
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer Start of enrollment: 2022 Jan 01
Recruiting
Roles: Contact
LOWER: Lomitapide Observational Worldwide Evaluation Registry Start of enrollment: 2014 Mar 18
Recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

LL-37: A Direct Link Between Inflammation and Myocardial Infarction.
David J Schneider
JACC. Basic to Translational Science. 2024-07-01
Timing of Revascularization in Patients With Acute Coronary Syndrome: Why Is Earlier Better?
David J Schneider
The American Journal of Cardiology. 2024-07-01
1 citations
Plasma Soluble Glycoprotein VI: A Biomarker of Bleeding.
David J Schneider
Thrombosis and Haemostasis. 2024-04-01

Press Mentions

FcγRIIa: A Marker of Cardiovascular Risk After Myocardial InfarctionOctober 21st, 2024
What’s the Point of Plants That Make Us Feel High?March 5th, 2020

Professional Memberships

American College of Cardiology - ACC
Member